Full Coverage
Ketamine-Derived Drug Spravato For Major Depression Gets FDA Approval : Shots - Health News
By Jon Hamilton
Top news
Nasal spray drug related to ketamine approved by FDA to treat depression
By Shamard Charles
Esketamine: FDA approves new antidepressant to treat most debilitating cases
By Carolyn Johnson & Laurie McGinley
Janssen Announces U.S. FDA Approval of SPRAVATO™ (esketamine) CIII Nasal Spray for Adults with Treatment ...
Esketamine, New Depression Drug From Johnson & Johnson, Approved by FDA
By Erin Brodwin
All coverage
FDA approves esketamine, the first major depression treatment to reach U.S. market in decades
By Megan Thielking
FDA approves ketamine-like nasal spray for depression
By Debra Goldschmidt